Anzeige
Mehr »
Login
Dienstag, 19.03.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nach Milliarden-Deal - Übernahme-Karussell nimmt Fahrt auf!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DR6E | ISIN: CA60255C8850 | Ticker-Symbol: MMQ
Tradegate
19.03.24
09:54 Uhr
9,405 Euro
+0,280
+3,07 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
MIND MEDICINE MINDMED INC Chart 1 Jahr
5-Tage-Chart
MIND MEDICINE MINDMED INC 5-Tage-Chart
RealtimeGeldBriefZeit
9,4559,66010:31
9,4059,61010:09

Aktuelle News zur MIND MEDICINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoMNMD, SMR and VERI are among pre market gainers19
11.03.MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference283Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders...
► Artikel lesen
08.03.MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds12
08.03.MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag11
08.03.Numinus Wellness Inc: Numinus congratulates Mind Medicine on MM120 trial4
08.03.Numinus Wellness Inc.: Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder114VANCOUVER, BC, March 8, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral...
► Artikel lesen
08.03.MindMed gets FDA breakthrough tag for LSD in anxiety9
07.03.MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials17
07.03.Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation15
07.03.Why Is MindMed (MNMD) Stock Up 32% Today?21
07.03.MindMed Receives FDA Breakthrough Therapy Designation For MM120; Stock Up8
07.03.Mind Medicine (MindMed) Inc (2): MindMed's MM120 receives FDA breakthrough designation6
07.03.Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement267Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...
► Artikel lesen
07.03.Mind Medicine Inc. - 8-K, Current Report5
07.03.MindMed rises on 'breakthrough therapy' tag for anxiety treatment10
07.03.Mind Medicine stock rises on FDA breakthrough status for anxiety disorder therapy17
01.03.Mind Medicine (MindMed) Inc (2): Mind Medicine to discuss MM120 in March 7 call15
01.03.MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120266Data update includes 12-week topline Phase 2b results for MM120 in Generalized Anxiety Disorder (GAD) - - Results from Phase 1 pharmacokinetics bridging trial for MM120 oral dissolving tablet...
► Artikel lesen
28.02.MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses11
28.02.Mind Medicine (MindMed) Inc (2): Mind Medicine spends $52.12-million on R&D in 20234
Seite:  Weiter >>
69 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,4